Clinical Trials Directory

Trials / Completed

CompletedNCT00213070

Double-Blind Trial of Miglitol in Type 2 Diabetic Patients With Insulin Treatment

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
Sponsor
Sanwa Kagaku Kenkyusho Co., Ltd. · Industry
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is evaluate the clinical efficacy and safety of Miglitol in patients with Type2 Diabetes Mellitus with treated insulin.

Conditions

Interventions

TypeNameDescription
DRUGMiglitol

Timeline

First posted
2005-09-21
Last updated
2006-09-21

Locations

16 sites across 1 country: Japan

Source: ClinicalTrials.gov record NCT00213070. Inclusion in this directory is not an endorsement.